XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Cameron Turtle [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 20, 2025, Cameron Turtle, our Chief Executive Officer, terminated a trading plan dated April 12, 2024 intended to satisfy Rule 10b5-1(c) to sell up to 300,000 shares of our common stock over a period ending November 19, 2026, subject to certain conditions, and adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 360,000 shares of our common stock over a period ending August 4, 2027, subject to certain conditions.
Sheldon Sloan [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On June 20, 2025, Sheldon Sloan, our Chief Medical Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 102,958 shares of our common stock over a period ending September 3, 2026, subject to certain conditions, all of which shares are to be acquired upon the exercise of employee stock options.
Name Sheldon Sloan
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 20, 2025
Expiration Date September 3, 2026
Arrangement Duration 440 days
Aggregate Available 102,958
Cameron Turtle April 2024 Plan [Member] | Cameron Turtle [Member]  
Trading Arrangements, by Individual  
Name Cameron Turtle
Title Chief Executive Officer
Rule 10b5-1 Arrangement Terminated true
Termination Date June 20, 2025
Aggregate Available 300,000
Cameron Turtle June 2025 Plan [Member] | Cameron Turtle [Member]  
Trading Arrangements, by Individual  
Name Cameron Turtle
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 20, 2025
Expiration Date August 4, 2027
Arrangement Duration 775 days
Aggregate Available 360,000